Lynne Kaminer to Leukemia, Myeloid, Acute
This is a "connection" page, showing publications Lynne Kaminer has written about Leukemia, Myeloid, Acute.
Connection Strength
0.276
-
Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial. Leuk Res. 2021 12; 111:106736.
Score: 0.132
-
Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia. Cancer. 1990 Jun 15; 65(12):2619-23.
Score: 0.060
-
Oxaliplatin-related acute myelogenous leukemia. Oncologist. 2006 Mar; 11(3):261-2.
Score: 0.044
-
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490). Ann Oncol. 1999 Feb; 10(2):177-82.
Score: 0.027
-
Variant translocations (9;11): identification of the critical genetic rearrangement. Cancer Genet Cytogenet. 1988 Jan; 30(1):171-5.
Score: 0.013